For: | Milind R, Attwood SE. Natural history of Barrett's esophagus. World J Gastroenterol 2012; 18(27): 3483-3491 [PMID: 22826612 DOI: 10.3748/wjg.v18.i27.3483] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v18/i27/3483.htm |
Number | Citing Articles |
1 |
Ishaan Maitra, Camilo L. M. Morais, Kássio M. G. Lima, Katherine M. Ashton, Ravindra S. Date, Francis L. Martin. Raman spectral discrimination in human liquid biopsies of oesophageal transformation to adenocarcinoma. Journal of Biophotonics 2020; 13(3) doi: 10.1002/jbio.201960132
|
2 |
Hyun Jin Jo, Hye Seung Lee, Nayoung Kim, Ryoung Hee Nam, Hyun Chang, Min Soo Kim, Sung Eun Kim, Jane C Oh, Dong Ho Lee, Hyun Chae Jung. Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. Journal of Neurogastroenterology and Motility 2013; 19(2): 210 doi: 10.5056/jnm.2013.19.2.210
|
3 |
Stephen Attwood. New Barrett's guidelines: an opportunity to improve patient experience and save resources. Frontline Gastroenterology 2015; 6(1): 4 doi: 10.1136/flgastro-2014-100486
|
4 |
Young-Min Han, Jong-Min Park, Ho-Jae Lee, Eun-Hee Kim, Ki Baik Hahm. Short-term Intervention to Revert Premalignant Lesions as Strategy to Prevent Gastrointestinal Cancers. Journal of Cancer Prevention 2013; 18(4): 289 doi: 10.15430/JCP.2013.18.4.289
|
5 |
Matthew J. Whitson, Gary W. Falk. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett’s Esophagus. Gastroenterology Clinics of North America 2015; 44(2): 299 doi: 10.1016/j.gtc.2015.02.005
|
6 |
Ishaan Maitra, Camilo L. M. Morais, Kássio M. G. Lima, Katherine M. Ashton, Ravindra S. Date, Francis L. Martin. Attenuated total reflection Fourier-transform infrared spectral discrimination in human bodily fluids of oesophageal transformation to adenocarcinoma. The Analyst 2019; 144(24): 7447 doi: 10.1039/C9AN01749F
|
7 |
Stuart A. C. McDonald, Danielle Lavery, Nicholas A. Wright, Marnix Jansen. Barrett oesophagus: lessons on its origins from the lesion itself. Nature Reviews Gastroenterology & Hepatology 2015; 12(1): 50 doi: 10.1038/nrgastro.2014.181
|
8 |
Ishaan Maitra, Camilo L.M. Morais, Kássio M.G. Lima, Katherine M. Ashton, Danielle Bury, Ravindra S. Date, Francis L. Martin. Discrimination of oesophageal transformation stages to adenocarcinoma in human tissue samples using Raman microspectroscopy. Vibrational Spectroscopy 2020; 111: 103141 doi: 10.1016/j.vibspec.2020.103141
|
9 |
Ellen H. Morrow, Brant K. Oelschlager. Surgical Management of Benign Esophageal Disorders. 2014; : 215 doi: 10.1007/978-1-4471-5484-6_16
|
10 |
Chidi Amadi, Piers Gatenby. Barrett’s oesophagus: Current controversies. World Journal of Gastroenterology 2017; 23(28): 5051-5067 doi: 10.3748/wjg.v23.i28.5051
|
11 |
Francesca M. Dimou, Candace Gonzalez, Vic Velanovich. Hiatal Hernia Surgery. 2018; : 1 doi: 10.1007/978-3-319-64003-7_1
|
12 |
Scott M. Langevin, Dominique S. Michaud, Carmen J. Marsit, Heather H. Nelson, Ariel E. Birnbaum, Melissa Eliot, Brock C. Christensen, Michael D. McClean, Karl T. Kelsey. Gastric Reflux Is an Independent Risk Factor for Laryngopharyngeal Carcinoma. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(6): 1061 doi: 10.1158/1055-9965.EPI-13-0183
|
13 |
Z. Babic, Z. Bogdanovic, Z. Dorosulic, Z. Petrovic, M. Kujundzic, M. Banic, M. Marusic, R. Heinzl, B. Bilić, M. Andabak. One year treatment of Barrett’s oesophagus with proton pump inhibitors (a multi-center study). Acta Clinica Belgica 2015; 70(6): 408 doi: 10.1179/2295333715Y.0000000050
|
14 |
Georgina E. Riddiough, Steve T. Hornby, Khashayar Asadi, Ahmed Aly. Gastric adenocarinoma of the upper oesophagus: A literature review and case report. International Journal of Surgery Case Reports 2017; 30: 205 doi: 10.1016/j.ijscr.2016.11.014
|
15 |
Z. Babic, Z. Bogdanovic, Z. Dorosulic, Z. Petrovic, M. Kujundzic, M. Banic, M. Marusic, R. Heinzl, B. Bilić, M. Andabak. One year treatment of Barrett’s oesophagus with proton pump inhibitors (a multi-center study). Acta Clinica Belgica 2015; 70(6): 408 doi: 10.1179/2295333715Y.0000000050
|
16 |
Yinin Hu, Varun Puri, Vanessa M. Shami, George J. Stukenborg, Benjamin D. Kozower. Comparative Effectiveness of Esophagectomy Versus Endoscopic Treatment for Esophageal High-grade Dysplasia. Annals of Surgery 2016; 263(4): 719 doi: 10.1097/SLA.0000000000001387
|
17 |
Ellen Morrow, Daniel Bushyhead, Eelco Wassenaar, Marcelo Hinojosa, Maximiliano Loviscek, Carlos Pellegrini, Brant Oelschlager. The impact of laparoscopic anti-reflux surgery in patients with Barrett’s esophagus. Surgical Endoscopy 2014; 28(12): 3279 doi: 10.1007/s00464-014-3601-z
|
18 |
Nipun B. Merchant, Sudhir K. Dutta, Mohit Girotra, Manish Arora, Stephen J. Meltzer. Evidence for Enhanced Telomerase Activity in Barrett's Esophagus with Dysplasia and Adenocarcinoma. Asian Pacific Journal of Cancer Prevention 2013; 14(2): 679 doi: 10.7314/APJCP.2013.14.2.679
|
19 |
Martin J. Connor, Laurie R. Springford, Venediktos V. Kapetanakis, Stefano Giuliani. Esophageal atresia and transitional care—step 1: a systematic review and meta-analysis of the literature to define the prevalence of chronic long-term problems. The American Journal of Surgery 2015; 209(4): 747 doi: 10.1016/j.amjsurg.2014.09.019
|
20 |
Jason T. Lewis. Surgical Pathology of Non-neoplastic Gastrointestinal Diseases. 2019; : 41 doi: 10.1007/978-3-030-15573-5_3
|
21 |
Junya Oguma, Soji Ozawa, Akihito Kazuno, Miho Nitta, Yamato Ninomiya, Sakura Tomita. Two-year follow-up period showing the natural history of a superficial esophageal adenocarcinoma arising in a long segment of Barrett’s esophagus. Clinical Journal of Gastroenterology 2016; 9(5): 289 doi: 10.1007/s12328-016-0681-4
|
22 |
Mohammad S. Al-Zahrani, Ahmed A. Alhassani, Khalid H. Zawawi. Clinical manifestations of gastrointestinal diseases in the oral cavity. The Saudi Dental Journal 2021; 33(8): 835 doi: 10.1016/j.sdentj.2021.09.017
|
23 |
David A. Johnson, Philip O. Katz, David Armstrong, Henry Cohen, Brendan C. Delaney, Colin W. Howden, Peter Katelaris, Radu I. Tutuian, Donald O. Castell. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus. Drugs 2017; 77(5): 547 doi: 10.1007/s40265-017-0712-6
|